α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein

Journal of Neuroscience Research

Volumn 84, Issue 1, 2006, Pages 68-77

  Fowler, Jill H ^a,b   Edgar, J M ^a   Pringle, A ^a   McLaughlin, M ^a   McCulloch, J ^b   Griffiths, I R ^a   Garbern, J Y ^c   Nave, K A ^d   Dewar, D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Glial axonal interactions; Glutamate receptors; Oligodendrocytes; White matter damage

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR 2; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CAUDATE NUCLEUS; CONTROLLED STUDY; EXCITOTOXICITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL LESION; NEUROFILAMENT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; STRIATE CORTEX; WESTERN BLOTTING; WILD TYPE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; AXONS; BLOTTING, WESTERN; BRAIN INJURIES; CYTOSKELETAL PROTEINS; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, MUTANT STRAINS; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; RECEPTORS, GLUTAMATE;

EID: 33745791099     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20859     Document Type: Article

References (42)

1. Blumbergs PC, Scott G, Wainwright H, Simpson DA, McLean AJ. 1994. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344:1055-1056.
2. Brand-Schieber E, Werner P. 2003a. AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and nodes of Ranvier. Glia 42:12-24.
3. Brand-Schieber E, Werner P. 2003b. (+/-)-Alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid and kainate receptor subunit expression in mouse vs. rat spinal cord white matter: similarities in astrocytes but differences in oligodendrocytes. Neurosci Lett 345:126-130.
4. Coleman M. 2005. Axonal degeneration mechanisms: commonality and diversity. Nat Rev Neurosci 6:889-898.
5. Cuthill DJ, Fowler JH, McCulloch J, Dewar D. 2006. Different Patterns of axonal damage after intracerebral injection of Malonate or AMPA. Exp Neurol (in press).
6. De Cozar M, Lucas M, Monreal J. 1987. Ionotrophic properties of the proteolipid apoprotein from bovine brain myelin. Biochem Int 14:833-841.
7. Dewar D, Yam P, McCulloch J. 1999. Drug development for stroke: importance of protecting white matter. Eur J Pharmacol 375:41-50.
8. Edgar JM, McLaughlin M, Yool D, Zhang S-C, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan I, Garbern J, Nave KA, Griffiths IR. 2004. Oligodendroglial modulation of retrograde axonal transport in a mouse model of spastic paraplegia. J Cell Biol 166:121-131.
9. Ferguson B, Matysak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
10. Fowler JH, McCracken E, McCulloch J, Dewar D. 2003. Intracerebral injection of AMPA causes axonal damage in vivo. Brain Res 991:104-112.
11. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
12. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave K-A, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
13. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmerman F, McCulloch M, Nadon N, Nave K-A. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
14. Gudz TI, Schneider TE, Haas TA, Macklin WB. 2002. Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes. J Neurosci 22:7398-7407.
15. Gudz TI, Homuro H, Macklin WB. 2004. Glutamate stimulates oligodendrocyte migration mediated by an αV-integrin/PLP complex. Soc Neurosci Abstr148.2.
16. Kanellopoulos GK, Xu XM, Hsu CY, Lu X, Sundt TM, Kouchoukos NT. 2000. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 31:1945-1952.
17. Kitagawa K, Sinoway MP, Yang C, Gould RM, Colman DR. 1993. A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron 11:433-438.
18. Klugmann M, Scwab MH, Puklhofer A, Schneider A, Zimmerman F, Griffiths IR, Nave K-A. 1997. Assembly of CNS myelin in the absence of Proteolipid protein. Neuron 18:59-70.
19. Li S, Stys PK. 2000. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 20:1190-1196.
20. Marmarou CR, Povlishock JT. 2006. Administration of the immunophilin FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury. Exp Neurol 197:353-362.
21. Marmarou CR, Walker SA, Davis CL, Povlishock JT. 2005. Quantitative analysis of the relationship between intra-axonal neurofilament compaction and impaired axonal transport following diffuse brain injury. J Neurotrauma 22:1066-1080.
22. Matute C. 1998. Characteristics of acute and chronic excitotoxic damage to the optic nerve. Proc Natl Acad Sci U S A 95:10229-10234.
23. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. 1997. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A 94:8830-8835.
24. McCracken E, Fowler JH, Dewar D, Morrison S, McCulloch J. 2002. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 22:1090-1097.
25. McDonald JW. Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. 1998a. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4:291-297.
26. McDonald JW, Levine JM, Qu Y. 1998b. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity. Neuroreport 9:2757-2762.
27. Miller MJ, Haxhiu MA, Georgiadis P, Gudz TI, Kangas CD, Macklin WB. 2003. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. J Neurosci 23:2265-2273.
28. Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE, Bell GI. 1992. Glutamate transporter expression in the brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridisation. J Biol Chem 267:467-472.
29. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. 1994. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12:357-371.
30. Pitt D, Werner P, Raine CS. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67-70.
31. Rosenberg LJ, Teng YD, Wrathall JR. 1999. 2, 3-Dihydroxy-6-nitro-7 sulfamoyl-benzo(f) quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 19:464-475.
32. Sanchez-Gomez MA, Matute C. 1999. AMPA and kainate receptors mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis 6:475-485.
33. Sasaki S, Iwata M. 1999. Immunoreactivity of β-amyoid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol 97:463-468.
34. Sheller RA, Tytell M, Smyers M, Bittner GD. 1995. Glia-to-axon communication: enrichment of glial proteins transferred to the squid giant axon. J Neurosci Res 41:324-334.
35. Stone JR, Singleton RH, Povlishock JT. 2001. Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons. Exp Neurol 172:320-331.
36. Stys PK. 1998. Anoxic and Ischemic injury of myelinated axons in the central nervous system white matter. J Cereb Blood Flow Metab 18:2-25.
37. Tekkok SB, Goldberg MP. 2001. AMPA/Kainate receptor activation mediated hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21:4237-4248.
38. Thomson CE, Anderson TJ, McCulloch MC, Dickinson PJ, Vouyiouklis DA, Griffiths IR. 1999. The early phenotype associated with the jimpy mutation of the proteolipid protein gene. J Neurocytol 28:207-221.
39. Wrathall JR, Choinire D, Teng YD. 1994. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 14:6598-6607.
40. Wrathall JR, Teng YD, Marriot R. 1997. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol 145:565-573.
41. Yang X, Skoff RP. 1997. Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J Neurosci 17:2056-2070.
42. Yoshoika A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. 1995. α-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64:2442-2448.